Relapsed/Refractory - Globe Thesis

Keyword [Relapsed/Refractory] Result: 21 - 40 \| Page: 2 of 4
21.	Meta-analysis Of The Efficacy Of DAC And D-CAG Regimens In The Treatment Of Elderly AML And RR-AML
22.	Molecular Markers On Drug Resistance Of Activated B Cell Type Diffuse Large B Cell Lhympoma
23.	Analysis On Clinical Efficacy And The Related Influencing Factors Of Decitabine-Based And Traditional Regimens In Treatment Of Relapsed/Refractory Acute Myeloid Leukemia
24.	A Single-center,Open,One-arm Clinical Study Of The Safety And Efficacy Of Infusion Of Anti-BCMA CAR-T For Relapsed/Refractory/High-risk BCMA+ Tumors
25.	Changes Of Cytokine Levels After Relapsed/refractory B-ALL Treated With CD19 CAR-T Cells And Its Clinical Significance
26.	Efficacy And Safety Of Programmed Death Protein-1(PD-1)inhibitor Monotherapy In The Treatment Of Relapsed/Refractory Lymphoma:A Meta-analysis
27.	Efficacy And Safety Of Pomalidomide In Relapsed Refractory Multiple Myeloma:A Meta-analysis
28.	The Role Of MiR-202-3p And MiR-15b-5p In Relapsed/refractory Normal Kayotype Acute Myeloid Leukemia Based On Online Database
29.	The Clinical Observation Of The Modified BACOD Regimen Combined With Recombinant Mutated Human Tumor Necrosis Factor For Relapsed/refractory Diffuse Large B-cell Lymphoma
30.	Analysis Of The Efficacy,Side Effects And Prognostic Factors Of DA-EPOCH±R Regimen And Modified ESHAP±R Regimen For Relapsed/Refractory Diffuse Large B-cell Lymphoma
31.	CAR19-T Cells Secreting IL-21 And PD1-Fc For The Treatment Of Relapsed/refractory Diffuse Large B Cell Lymphoma
32.	Clinical Efficacy And Safety Analysis Of Apatinib In The Treatment Of Relapsed And Refractory Diffuse Large B-cell Lymphoma
33.	Clinical Study Of Chimeric Antigen Receptor T Cell In Relapsed/Refractory B Cell Non-Hodgkin’s Lymphoma
34.	A Meta-analysis Of The Efficacy Of CAR-T In The Treatment Of Relapsed/refractory DLBCL
35.	Study Of Efficacy,safety And Pharmacokinetic Characteristics Of Lenalidomide Combined With Low-dose Dexamethasone In The Treatment Of Relapsed Refractory Multiple Myeloma
36.	Efficacy And Safety Of CD19 CAR T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphocytic Leukemia With Central Nervous System Invasion
37.	A Preliminary Study On The Safety And Efficacy Of CD19-targeted Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed/refractory Philadelphia Chromosome Positive Acute B Lymphocytic Leukemia
38.	The Efficacy And Safety Of Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed/refractory B-cell Acute Lymphoblastic Leukemia
39.	The cycle of relapsed/refractory disease among young adults with lymphoma: A grounded theory study
40.	LIN28A Regulates The Progression And Chemotherapy Resistance Of Acute Myeloid Leukemia By CENPE
<<First <Prev Next> Last>> Jump to